BR112013007198A2 - peptídeos do veneno do escorpião rhopalurus junceus e composições farmacêuticas - Google Patents

peptídeos do veneno do escorpião rhopalurus junceus e composições farmacêuticas

Info

Publication number
BR112013007198A2
BR112013007198A2 BR112013007198A BR112013007198A BR112013007198A2 BR 112013007198 A2 BR112013007198 A2 BR 112013007198A2 BR 112013007198 A BR112013007198 A BR 112013007198A BR 112013007198 A BR112013007198 A BR 112013007198A BR 112013007198 A2 BR112013007198 A2 BR 112013007198A2
Authority
BR
Brazil
Prior art keywords
scorpion venom
pharmaceutical compositions
peptides
rhopalurus
rhopalurus junceus
Prior art date
Application number
BR112013007198A
Other languages
English (en)
Inventor
Alexis Diaz Garcia
Caridad Clara Rodríguez Torres
Irania Guevara Orellana
Isbel González Marrero
José Antonio Fraga Castro
Judith Rodriguez Coipel
Maria Regla Pérez Capote
Regla María Medina Gali
Yanelis Riquenes Garlobo
Original Assignee
Grupo Empresarial De Producciones Biofarmaceuticas Y Quimicas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grupo Empresarial De Producciones Biofarmaceuticas Y Quimicas filed Critical Grupo Empresarial De Producciones Biofarmaceuticas Y Quimicas
Publication of BR112013007198A2 publication Critical patent/BR112013007198A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

peptídeos do veneno do escorpião rhopalurus junceus e composições farmacêuticas. o presente pedido de patente de invenção está relacionado a novos peptídeos obtidos a partir do venono do escorpião rhopalurus junceus o qual é caracterizado por um alto teor em proteínas, lipídios, carboidratos, aminoácidos, sais inorgânicos e outros íons incluindo peptídeos como princípios ativos; o presente pedido de patente de invenção também inclui uma formulação utilizada como medicamento por suas propriedades como anticancerígeno, analgésico e antiinflamatório, que levem à elevação dos índices de melhora da qualidade de vida em pacientes com doenças oncológicas.
BR112013007198A 2010-09-27 2011-09-27 peptídeos do veneno do escorpião rhopalurus junceus e composições farmacêuticas BR112013007198A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU2010000186A CU24055B1 (es) 2010-09-27 2010-09-27 Composiciones farmacéuticas de veneno de escorpión rhopalurus junceus
PCT/CU2011/000006 WO2012041261A2 (es) 2010-09-27 2011-09-27 Peptidos del veneno de escorpion rhopalorus junceus y composicion farmaceutica

Publications (1)

Publication Number Publication Date
BR112013007198A2 true BR112013007198A2 (pt) 2016-06-14

Family

ID=45566782

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013007198A BR112013007198A2 (pt) 2010-09-27 2011-09-27 peptídeos do veneno do escorpião rhopalurus junceus e composições farmacêuticas

Country Status (17)

Country Link
EP (1) EP2623111A2 (pt)
JP (1) JP2013542196A (pt)
KR (1) KR20140041381A (pt)
CN (1) CN103200951A (pt)
AP (1) AP2013006811A0 (pt)
AR (1) AR083117A1 (pt)
AU (1) AU2011307691A1 (pt)
BR (1) BR112013007198A2 (pt)
CA (1) CA2812841A1 (pt)
CO (1) CO6781464A2 (pt)
CU (1) CU24055B1 (pt)
EC (1) ECSP13012595A (pt)
IL (1) IL225577A0 (pt)
MX (1) MX360726B (pt)
RU (1) RU2563348C2 (pt)
SG (1) SG191708A1 (pt)
WO (1) WO2012041261A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103074304B (zh) * 2013-01-28 2016-01-13 江苏健安生物科技有限公司 高水平人二倍体细胞培养水痘-带状疱疹疫苗病毒方法
MX2019000570A (es) * 2018-12-19 2020-08-13 Centro De Investig Biologicas Del Noroeste S C Composición homeopatica a base de veneno de escorpión rhopalurus junceus y su uso en acuicultura.
CA3206293A1 (en) * 2020-12-22 2022-06-30 PreveCeutical Medical Inc. Cyclic peptides and uses thereof
CN113384682B (zh) * 2021-05-31 2023-07-04 南方医科大学 蝎毒多肽Smp43在制备抗肿瘤药物的应用
CN117069800B (zh) * 2023-10-16 2023-12-12 山东省食品药品检验研究院 一种鉴别东亚钳蝎的特征多肽及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030229C (zh) 1991-12-16 1995-11-08 山东省蒙阴县酒厂 全蝎酒的制作方法
CN1076858A (zh) 1993-03-24 1993-10-06 王强华 熊胆全蝎酒及其制备工艺
CU22413A1 (es) 1994-01-11 1996-01-31 Composicion antitumoral
US5905027A (en) 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
FR2745004B1 (fr) * 1996-02-16 1998-03-27 Rhone Poulenc Agrochimie Peptide antibacterien et antifongique
US6168651B1 (en) 1998-10-08 2001-01-02 Donaldson Company, Inc. Filter assembly with shaped adsorbent article; and devices and methods of use
CN1279088A (zh) 1999-06-25 2001-01-10 谷令旗 一种治疗肝癌药剂的制备方法
CN1265901A (zh) 2000-01-26 2000-09-13 徐忠廷 一种抗癌中药丸剂
CN1316249A (zh) 2001-04-04 2001-10-10 李滋星 全蝎活性营养液
CN1157215C (zh) 2001-07-30 2004-07-14 张官锁 一种治疗癌症的中药组合物
CN1325514C (zh) * 2001-09-30 2007-07-11 沈阳药科大学 蝎镇痛抗肿瘤缬精甘肽及获得方法
CN100465272C (zh) * 2002-01-18 2009-03-04 中国科学院上海有机化学研究所 重组东亚马氏钳蝎毒rBmKaIT1的基因工程
AU2003240496B2 (en) * 2002-05-31 2008-01-10 Eisai Inc. Combination chemotherapy with chlorotoxin
CN1256971C (zh) 2002-08-12 2006-05-24 徐继康 一种用于治疗肿瘤的中药胶囊
US8097284B2 (en) * 2007-11-13 2012-01-17 Arthur Mikaelian Polarized scorpion venom solution and a method for making polarized scorpion venom solution

Also Published As

Publication number Publication date
MX360726B (es) 2018-11-13
CU20100186A7 (es) 2012-06-21
EP2623111A2 (en) 2013-08-07
SG191708A1 (en) 2013-08-30
WO2012041261A2 (es) 2012-04-05
AR083117A1 (es) 2013-01-30
CN103200951A (zh) 2013-07-10
JP2013542196A (ja) 2013-11-21
ECSP13012595A (es) 2014-11-28
CU24055B1 (es) 2014-12-26
RU2013119431A (ru) 2014-11-10
AU2011307691A1 (en) 2013-05-02
KR20140041381A (ko) 2014-04-04
RU2563348C2 (ru) 2015-09-20
AP2013006811A0 (en) 2013-04-30
IL225577A0 (en) 2013-06-27
CO6781464A2 (es) 2013-10-31
WO2012041261A3 (es) 2012-11-22
CA2812841A1 (en) 2012-04-05
MX2013003545A (es) 2013-11-04

Similar Documents

Publication Publication Date Title
BR112015008297A2 (pt) antagonistas de mglu2/3 para o tratamento de distúrbios autistas
BR112014032699A2 (pt) métodos de tratamento de síndrome metabólica pediátrica
BR112015013095A8 (pt) Cânula nasal para distribuição de gás terapêutico a um paciente
BR112013007198A2 (pt) peptídeos do veneno do escorpião rhopalurus junceus e composições farmacêuticas
BR112013000255A2 (pt) ácidos hidróxifenil-hexinoicos substituídos por ariloxialquileno, método para preparação dos mesmos e seu uso dos mesmos como um medicamento
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BR112013000920A2 (pt) compostos para a redução de produção de beta-amiloide
BR112012022223A2 (pt) formulações de proteína concentrada e usos das mesmas
BR112012011478A2 (pt) composições fosfolipídicas terapêuticas concentradas.
BR112015003188A2 (pt) Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
CA2863964C (en) Compartmentalized method of nucleic acid delivery and compositions and uses thereof
BR112014003414A2 (pt) método de produção de níveis fisiológicos e terapêuticos de óxido nítrico através de um sistema de entrega oral
EA201390409A1 (ru) Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием
BR112014019667A2 (pt) formulação de anticorpo abeta
EA201390332A1 (ru) Дейтерированные аналоги придопидина, применимые в качестве допаминергических стабилизаторов
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
BR112013006344A2 (pt) lactamas substituídas por piperdinila como moduladores de gpr119, composição farmacêutica as compreendendo, uso e processso para preparação das mesmas
BR112014008036A2 (pt) tratamento de rinite
BR112013026257A2 (pt) derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes
BR112015010396A2 (pt) terapia de combinação
BR112014021653A2 (pt) Formulação tópica, método para tratamento de feridas e método para fabricar uma formulação tópica
BR112013031652A2 (pt) métodos de tratamento para doenças retinais
BR112013020586A2 (pt) Uso de células derivadas de tecido do cordão umbilical
BR112013026698A2 (pt) formulações do tipo tópica compreendendo depsipeptídeo cíclico
BR112013030391A2 (pt) derivados de piperidina 3- espirocíclicos como agonistas dos receptores de grelina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.